Benzinga All Access event on July 15, 2022 TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced that Chris Seto, CEO, and Dr. John Kellum, CMO, of Spectral Medical, will be participating at the Benzinga All Access event taking place on July 15, 2022. Mr. Seto and Dr. Kellum are scheduled to present at 10:20 a.m. Eastern Time, Friday, July 15.
The event will be broadcast live and can be viewed at Benzinga All Access.
A recording of the presentation will be made available on Spectral’s website under the investor relations section at https://spectraldx.com/investors/
https://finance.yahoo.com/news/spectral-medical-participate-benzinga-access-120000355.html